This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The NTC was an intensive mass media anti-smoking campaign, the first phase of which ran from June to November 1997. It involved intensive new anti-smoking advertisements on television and a range of support services, especially quit lines for smokers who were attempting to quit. The comparator was the care delivered before the implementation of the intervention.
Location/setting
Australia/community.
Methods

Analytical approach:
The economic evaluation used a Markov model, namely the quit benefits model (QBM), which predicted the benefits of smoking cessation in quitters taking account of four main smoking-associated diseases. The time horizon of the model was a lifetime (up to the age of 85 years). The authors stated that the perspective of the health care system was adopted.
Effectiveness data:
The clinical data came from a selection of known, relevant sources, including published studies and the report of the programme implementation which gathered data by means of household telephone surveys. Around 2,000 Australians aged 18 and over were interviewed in May 1997 and around 4,200 were interviewed in November 1997. The bulk of the evidence came from Australian sources and was supplemented by data from international studies when required. The primary clinical outcome was the reduction in smoking prevalence due to the anti-smoking campaign.
Monetary benefit and utility valuations:
The utility estimates came from two published sources, which were a meta-regression of 20 studies and an international registry. No other details were given.
Measure of benefit:
The two summary benefit measures were life-years (LYs) and quality-adjusted life-years (QALYs). Both were calculated using the QBM and were discounted at an annual rate of 3%. The number of avoided cases of the four smoking-associated diseases, which were lung cancer (LC), acute myocardial infarction (AMI), stroke, and chronic obstructive pulmonary disease (COPD), were also reported.
